Profex, Inc., a dermatology drug company headquartered in Shanghai, raised $15.5 million in a Series A financing. The round was led by Trident Capital, an international venture capital firm, and joined by Mustang Ventures, Trident’s partner in China venture investing. The new capital will be used to increase the company’s sales efforts and to extend its geographical reach inside China. More details...